UV Flu Technologies Inc. develops highly innovative air purification technology that purifies indoor air by killing airborne bacteria. The Company’s flagship product, ViraTech® RX-400 model, utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtering to destroy harmful bacteria. Extensive independent testing by EPA- and FDA-certified laboratories confirms the proprietary system kills airborne bacteria at rates exceeding 99% on a first-pass basis. Increased media attention and growing public concern over the rise of the H1N1 swine flu pandemic, antibiotic-resistant superbugs, asthma, allergies, tuberculosis, Sick Building Syndrome and toxic mold are spurring governments, employers and homeowners to take action to safeguard their health.
Our goal is to provide customers with the highest quality products and service at competitive prices; to achieve industry and customer recognition as a global leader; to deliver consistent profitability from an organization that leads its sector in productivity and customer loyalty; to achieve a market leading CAGR (Compound Annual Growth Rate); to create a dynamic organization, employing sound business policies that will enhance our commitment to quality, integrity, and excellence; and finally to reward innovative thinking and true leadership and to provide a structure that leverages and aligns these values and capabilities to achieve our common goals.
250 Parkway Drive Suite 150
Lincolnshire, IL 60069
Discount Sales and Product Info